These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10021477)

  • 1. New resistance in Staphylococcus aureus.
    Waldvogel FA
    N Engl J Med; 1999 Feb; 340(7):556-7. PubMed ID: 10021477
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin resistance in Staphylococcus aureus.
    John CC
    N Engl J Med; 1999 Jul; 341(3):207-8. PubMed ID: 10409039
    [No Abstract]   [Full Text] [Related]  

  • 3. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
    Sieradzki K; Roberts RB; Haber SW; Tomasz A
    N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472
    [No Abstract]   [Full Text] [Related]  

  • 4. Methicillin resistant Staphylococcus aureus.
    Salaria M; Singh M
    Indian Pediatr; 2001 Jan; 38(1):29-36. PubMed ID: 11175931
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for methicillin-resistant Staphylococcus aureus.
    Quintiliani R; Kuti J
    Conn Med; 2001 Jan; 65(1):23-5. PubMed ID: 11227621
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is the vancomycin resistance of Staphylococcus aureus left unnoticed?].
    Vuento R
    Duodecim; 1999; 115(19):2045-7. PubMed ID: 11941798
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin.
    Tattevin P; Arvieux C; Michelet C
    Arch Intern Med; 2007 Jun; 167(11):1206; author reply 1208-9. PubMed ID: 17563033
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance pattern of methicillin resistant Staphylococcus aureus.
    Pal N; Ayyagari A
    Indian Pediatr; 1991 Jul; 28(7):725-9. PubMed ID: 1800344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staph with lower vancomycin resistance in US.
    OR Manager; 1997 Oct; 13(10):7. PubMed ID: 10174189
    [No Abstract]   [Full Text] [Related]  

  • 14. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methicillin-resistant Staphylococcus aureus (MRSA) -- case report].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):581; quiz 589-92. PubMed ID: 15761786
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteomyelitis of the maxilla caused by methicillin-resistant Staphylococcus aureus.
    Cohen MA; Embil JM; Canosa T
    J Oral Maxillofac Surg; 2003 Mar; 61(3):387-90. PubMed ID: 12618981
    [No Abstract]   [Full Text] [Related]  

  • 20. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.